摘要
目的:研究内毒素对体外培养非小细胞肺癌(NSCLC)细胞株A549细胞增殖的影响及其机制。方法:不同浓度脂多糖(LPS)进行8-48h干预,MTT及细胞计数法检测其对A549细胞增殖的影响;EGFR中和抗体或COX-2抑制剂与LPS联合干预,检测其对A549细胞增殖及PGE2的影响。结果:LPS可引发A549细胞MTT活性和细胞计数显著增加,且呈现时间和剂量依赖性。LPS还可诱发PGE2水平显著升高。药物干预结果显示,抑制COX-2或EGFR可明显逆转LPS所引发的细胞增殖和PGE2水平升高趋势。结论:LPS可能通过激活EGFR和COX-2信号途径,诱导体外培养的非小细胞肺癌细胞增殖分化。肺部感染可能会加速非小细胞肺癌进展,并可能造成不良预后。
Objective: To investigate the effect of endotoxin on tumor proliferation in the non-small cell lung cancer and the underlying mechanisms. Methods: Different concentrations ofLipopolysaccharide (LPS) were intervented from 8 to 48 h. The effection of LPS on the proliferation of A549 cells with MTT and cell counting were tested. The intervention effect of the combination of EGFR neutralizing antibody or COX-2 inhibitors with LPS on the proliferation of A549 cells and PGE2 were tested. Results: LPS induced a time- and dose-dependent increase in proliferation of A549 cells as quantified by MTS activity and cell counting. Large amounts of COX-2-derived prostaglandin (PG) E2 were secreted from LPS-stimulated A549 cells. Pharmacological interventions revealed that inhibition of COX-2 and EGFR activity in A549 cells severely attenuated both PGE2 release and proliferation in response to LPS. Conclusion: LPS induces proliferation of NSCLC cells in vitro inhuman NSCLC specimen via EGFR- or COX-2-signaling. Pulmonary infection may thus directly induce tumor progression in NSCLC.
出处
《现代生物医学进展》
CAS
2014年第8期1449-1451,共3页
Progress in Modern Biomedicine
关键词
肺癌
内毒素
肿瘤增殖
Lung cancer
Endotoxin
Tumor proliferation